Objectives: A prolonged QRS duration has been associated with an unfavorable prognosis in chronic compensated heart failure (HF). However, its predictive value during an admission for acute HF is limited, even in HF with a preserved ejection fraction (EF). The purpose of this study was to evaluate the prognostic utility of the QRS duration in acute HF. Methods: Analyses were performed using data from 1,489 patients with a 2-year follow-up. The patients were selected from the Korean Acute Heart Failure Registry and were divided into three groups according to QRS duration (≤80, 81-119 or ≥120 ms). The all-cause mortality and readmission for HF were assessed. Results: During the study period, 774 primary events occurred (359 deaths and 415 HF). The event frequencies were higher in patients with a prolonged QRS duration. The increased risk associated with the QRS duration was also demonstrated after adjustment for cardiac outcome variables. The prognostic significance of the QRS duration was demonstrated in patients with reduced EF but not in those with a preserved EF. Conclusions: A prolonged QRS duration could be a significant predictor of the 2-year cardiac outcome in patients with acute HF, particularly in those with a reduced EF.

Keywords:
Acute heart failure, Korean Acute Heart Failure Registry, Prognosis, QRS duration
1.
Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN: QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002;143:1085-1091.
2.
Kalra PR, Sharma R, Shamim W, Doehner W, Wensel R, Bolger AP, Genth-Zotz S, Cicoira M, Coats AJ, Anker SD: Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 2002;86:225-231.
3.
Shenkman HJ, Pampati V, Khandelwal AK, McKinnon J, Nori D, Kaatz S, Sandberg KR, McCullough PA: Congestive heart failure and QRS duration: establishing prognosis study. Chest 2002;122:528-534.
4.
Hathaway WR, Peterson ED, Wagner GS, Granger CB, Zabel KM, Pieper KS, Clark KA, Woodlief LH, Califf RM: Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PAa for Occluded coronary Arteries. JAMA 1998;279:387-391.
5.
Guerrero M, Harjai K, Stone GW, Brodie B, Cox D, Boura J, Grines L, O'Neill W, Grines C: Comparison of the prognostic effect of left versus right versus no bundle branch block on presenting electrocardiogram in acute myocardial infarction patients treated with primary angioplasty in the primary angioplasty in myocardial infarction trials. Am J Cardiol 2005;96:482-488.
6.
Wong CK, Gao W, Stewart RA, French JK, Aylward PE, White HD: Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial. Heart 2009;95:276-282.
7.
Yerra L, Anavekar N, Skali H, Zelenkofske S, Velazquez E, McMurray J, Pfeffer M, Solomon SD: Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. Heart Rhythm 2006;3:313-316.
8.
Choi DJ, Han S, Jeon ES, Cho MC, Kim JJ, Yoo BS, Shin MS, Seong IW, Ahn Y, Kang SM, Kim YJ, Kim HS, Chae SC, Oh BH, Lee MM, Ryu KH: Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean Heart Failure Registry. Korean Circ J 2011;41:363-371.
9.
Rihal CS, Davis KB, Kennedy JW, Gersh BJ: The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. Am J Cardiol 1995;75:220-223.
10.
Christian TF, Miller TD, Chareonthaitawee P, Hodge DO, O'Connor MK, Gibbons RJ: Prevalence of normal resting left ventricular function with normal rest electrocardiograms. Am J Cardiol 1997;79:1295-1298.
11.
Murkofsky RL, Dangas G, Diamond JA, Mehta D, Schaffer A, Ambrose JA: A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction. J Am Coll Cardiol 1998;32:476-482.
12.
Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW, ADHERE Scientific Advisory Committee and Investigators: Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007;153:1021-1028.
13.
Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M: Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287:1541-1547.
14.
Shamim W, Francis DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD, Coats AJ: Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999;70:171-178.
15.
Sheridan DJ, Culling W, Penny WJ: Electrophysiological disturbances associated with acute myocardial infarction. Eur Heart J 1986;7(suppl B):11-18.
16.
Weston P, Johanson P, Schwartz LM, Maynard C, Jennings RB, Wagner GS: The value of both ST-segment and QRS complex changes during acute coronary occlusion for prediction of reperfusion-induced myocardial salvage in a canine model. J Electrocardiol 2007;40:18-25.
17.
Holmvang L, Lyck F, Clemmensen P, Behar V, Maynard C, Grande P, Wagner GS: Serial prognostic capabilities of electrocardiographic indices of infarcted and hibernating myocardium in predicting short- and long-term outcome following coronary artery bypass surgery. Cardiology 1997;88:333-339.
18.
Kornreich F, MacLeod RS, Dzavik V, Selvester RH, Kornreich AM, Stoupel E, de Almeida J, Walker D, Montague TJ: QRST changes during and after percutaneous transluminal coronary angioplasty. J Electrocardiol 1994;27(suppl):113-117.
19.
Mazzoleni A, Curtin ME, Wolff R, Reiner L, Somes G: On the relationship between heart weights, fibrosis, and QRS duration. J Electrocardiol 1975;8:233-236.
20.
Yamada T, Fukunami M, Ohmori M, Iwakura K, Kumagai K, Kondoh N, Tsujimura E, Abe Y, Nagareda T, Kotoh K: New approach to the estimation of the extent of myocardial fibrosis in patients with dilated cardiomyopathy: use of signal-averaged electrocardiography. Am Heart J 1993;126:626-631.
21.
Yontar OC, Yilmaz MB, Yalta K, Erdem A, Tandogan I: Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure. Arq Bras Cardiol 2010;95:738-742.
22.
El-Chami MF, Brancato C, Langberg J, Delurgio DB, Bush H, Brosius L, Leon AR: QRS duration is associated with atrial fibrillation in patients with left ventricular dysfunction. Clin Cardiol 2010;33:132-138.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.